Case Presentation
A 52-year-old man with dilated cardiomyopathy (left ventricular ejection fraction 25%), recently discharged from a heart failure (HF) admission, presented to the office with weakness and shortness of breath. On examination, his weight was stable, his blood pressure was 88/60 mm Hg, his jugular veins were difficult to assess owing to obesity, with a few bibasilar crackles, distant heart sounds with a 2/6 holosystolic murmur and a soft S3, a protruding abdomen, and 1 to 2+ pitting lower-extremity edema. Laboratory results showed a rise in creatinine from 1.5 to 2.6 mg/dL, a rise in serum urea nitrogen from 38 to 52 mg/dL, and a rise in brain natriuretic peptide from 106 to 280 pg/mL. This patient presented a clinical challenge, because it was not clear whether his symptoms were related to progressive HF with worsening cardiorenal syndrome, or conversely, to relative hypovolemia. Unfortunately, physical examination and laboratory studies can be misleading in the setting of HF exacerbation, 1 and changes in weight are known to lag behind important hemodynamic shifts. 2 Traditionally, this patient would likely have been hospitalized, with consideration of right heart catheterization if hemodynamic assessment were needed to guide further treatment. However, in our efforts to improve the quality and safety of care, with potentially competing imperatives to reduce readmissions, length of stay, and costs, 3 we must revisit our approach. The use of pulmonary artery flotation catheter monitoring requires intensive care unit or specialty unit hospitalization, has significant procedure-related risks, may not be accurate in all 
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conditions, 4 and has not been proven to be superior to standard care for patients with decompensated HF. 5 Fortunately, echo-Doppler, in addition to providing clinically useful information on the structure and function of cardiac chambers and valves, has now been shown to provide estimates of left-and right-sided filling pressures and cardiac output that correlate well with catheter-based hemodynamic values, 6 not only to allow care to be initiated promptly, but also to follow response to therapy. 7
Assessment of Right Atrial Pressure/Central Venous Pressure
Estimation of central venous pressure (CVP) and overall volume status can be facilitated by echocardiography via measurement of the inferior vena cava diameter and its change with respiration ( Figure 1 ). Current guidelines 8 review optimal imaging techniques, including issues in ventilated patients, and define normal and abnormal inferior vena cava values for estimation of CVP (Table) .
Pulmonary Artery Pressure
In patients with HF, the accurate assessment of pulmonary artery pressure (PAP) can be necessary to optimize patient care. Originally validated with invasive hemodynamics, 8 echo-Doppler evaluation of all PAP parameters, systolic (SPAP), mean PAP, and diastolic PAP, can be performed in most HF patients because the majority of HF patients have significant valvular regurgitation, 9 a requisite for complete Doppler analysis. Methods for obtaining PAP measurements are shown and detailed in Figure 2 and Table. In the absence of obstruction of the right ventricular outflow tract or the pulmonary valve, the noninvasive SPAP is derived from the sum of the CVP and the peak pressure gradient across the tricuspid valve between the right atrium and right ventricle during systole, obtained by spectral Doppler and calculated with the use of the simplified Bernoulli equation
. Although the Bernoulli method is generally accepted and used in daily practice, there is still debate regarding its validity, with some studies not being able to reproduce the high correlation with invasive measurements. 10 The inaccuracies in estimation (mostly underestimation) of SPAP are mostly attributable to certain patient populations such as those with emphysema, or when either the tricuspid regurgitation jet tracing is not complete or in the presence of wide-open tricuspid regurgitation. Also, in the setting of very high right atrial pressure, in which echocardiography may not accurately estimate right atrial pressure, the SPAP estimate will be affected. 11 Keeping in mind these same limitations, the mean PAP can be estimated either from the velocity time integral obtained by tracing the Doppler waveform used for obtaining the SPAP or using the peak pulmonic valve regurgitation jet velocity within the Bernoulli equation added to the CVP. With the use of this same calculation, the peak pulmonic valve regurgitation end-diastolic jet can be used for estimation of the diastolic PAP.
Pulmonary Capillary Wedge Pressure/Left Atrial Pressure
The echo-Doppler estimate of the pulmonary capillary wedge pressure (PCWP)/left atrial pressure (LAP) can provide clinically useful information such as the delineation of the etiology of pulmonary hypertension or measurement of the transpulmonary gradient for transplant candidacy. 12 For patients with at least moderate mitral regurgitation, the continuous wave mitral regurgitation tracing can be used to estimate the PCWP/LAP 13 ; however, the assessment of the PCWP/ LAP is most often done using parameters of diastolic function. 14 As shown in Figure 3 and Table, the commonly used parameters include mitral inflow velocities, tissue Doppler of the septal and lateral mitral annulus, spectral Doppler of the pulmonary venous flow, and left atrial size. Estimation of the LAP by echocardiography is best suited for differentiating high from low LAPs with overlap in patients with intermediate LAPs. A multiparameter approach has demonstrated a sensitivity and specificity for elevated PCWP/PAP of >85%. 15
Cardiac Output
The cardiac output is a product of the stroke volume multiplied by the heart rate. In the absence of significant aortic regurgitation, the velocity time integral of the Doppler signal obtained from the left ventricular outflow tract multiplied by the cross-sectional area of the left ventricular outflow tract allows a noninvasive estimation of the stroke volume, which has proven to be fairly accurate despite the generally oval shape of the left ventricular outflow tract (rather than the assumed circular shape in echo-Doppler measurements). 16 Obtaining the right-sided cardiac output is done in a similar fashion by using the right ventricular outflow tract velocity time integral and area, but may be more susceptible to inaccuracies, because the right ventricular outflow tract geometry is even more variable than the left ventricular outflow tract.
Case Summary/Discussion
In the patient presented, echocardiography was performed that day in the office, demonstrating a small, collapsing inferior vena cava (suggesting a CVP of <5 mm Hg), an estimated SPAP of 45 mm Hg, and diastolic parameters indicating low/normal PCWP/LAP. The calculated cardiac output was 3.9 L/ min. His diuretic dosage was reduced, with improvement in symptoms and normalization of laboratory results over the following week, thus avoiding hospitalization and invasive monitoring. At subsequent visits, these Doppler parameters were repeated when needed to assist in his care. This case illustrates the potential benefit of the proficiency of echocardiographic laboratories in hemodynamic measures and widespread availability of same-day, point-of-care studies. Echo-Doppler may also be useful for the serial assessment of acute hemodynamic interventions in hospitalized patients 17 and possibly in outpatient intravenous diuretic programs. Future advances in hand-held echocardiography (specifically its Doppler capability) and other measures, such as implantable hemodynamic monitoring devices, 18 may also prove helpful as hospital systems assume more responsibility for outcomes, overall costs, and the integration of inpatient and outpatient care.
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